Fadi Al Akhrass
- Type
- Physician · Allopathic & Osteopathic Physicians / Internal Medicine / Infectious Disease
- Where
- Pikeville, KY
- NPI
- 1245557222
- Received
- $311,268 in 572 records, 2019 to 2025
- As principal investigator
- $24,922 of research payments to others in 2 records
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 109 | $72,530 |
| 2024 | General payment | 82 | $51,907 |
| 2023 | General payment | 87 | $34,205 |
| 2022 | General payment | 80 | $35,565 |
| 2021 | General payment | 48 | $23,685 |
| 2020 | General payment | 44 | $26,459 |
| 2019 | General payment | 122 | $66,914 |
By company
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 104 | $215,685 |
| Travel and Lodging | 71 | $40,013 |
| Compensation for serving as faculty or as a speaker for a medical education program | 8 | $22,185 |
| Consulting Fee | 8 | $21,797 |
| Food and Beverage | 371 | $11,477 |
| Education | 10 | $110 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | Gilead Sciences, Inc. | $16 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-12-17 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-12-15 | Madrigal Pharmaceuticals | $465 | Consulting Fee | Cash or cash equivalent | 2025 | ||
| 2025-12-14 | Insmed, Inc. | $12 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-12-10 | Madrigal Pharmaceuticals | $775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-12-03 | ABBVIE INC. | $9 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-11-24 | Insmed, Inc. | $11 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-11-18 | Abbott Laboratories | $15 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2025 | |
| 2025-11-12 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-11-04 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | ZERBAXA Drug, INFECTIOUS DISEASE | 2025 | |
| 2025-10-27 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-10-24 | Gilead Sciences, Inc. | $600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Epclusa Drug, HCV | 2025 | |
| 2025-10-16 | ABBVIE INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-10-16 | Insmed, Inc. | $4 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-10-14 | Gilead Sciences, Inc. | $3,770 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Epclusa Drug, HCV | 2025 | |
| 2025-10-14 | Gilead Sciences, Inc. | $2,029 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Epclusa Drug, HCV | 2025 | |
| 2025-10-09 | Gilead Sciences, Inc. | $125 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2025 | |
| 2025-10-09 | Gilead Sciences, Inc. | $24 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2025 | |
| 2025-10-07 | ABBVIE INC. | $1,729 | Travel and Lodging | In-kind items and services | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-10-07 | ABBVIE INC. | $84 | Food and Beverage | In-kind items and services | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-10-02 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-10-02 | ABBVIE INC. | $1,350 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-09-29 | Gilead Sciences, Inc. | $22 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-09-25 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-09-24 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-09-23 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-09-22 | Insmed, Inc. | $24 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-09-16 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-09-09 | ABBVIE INC. | $58 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-09-09 | Merck Sharp & Dohme LLC | $18 | Food and Beverage | In-kind items and services | ZERBAXA Drug, INFECTIOUS DISEASE | 2025 | |
| 2025-09-02 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-08-27 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-08-26 | Insmed, Inc. | $11 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-08-20 | Shionogi Inc | $3,030 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2025 | |
| 2025-08-14 | Shionogi Inc | $124 | Food and Beverage | In-kind items and services | Fetroja Drug, Infections and Infectious Diseases | 2025 | |
| 2025-08-06 | Shionogi Inc | $4,545 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2025 | |
| 2025-07-31 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | ZERBAXA Drug, INFECTIOUS DISEASE | 2025 | |
| 2025-07-30 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-07-29 | Shionogi Inc | $1,668 | Travel and Lodging | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2025 | |
| 2025-07-25 | ABBVIE INC. | $3,600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-07-21 | Insmed, Inc. | $11 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-07-19 | Madrigal Pharmaceuticals | $94 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-18 | Madrigal Pharmaceuticals | $2,325 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-18 | Madrigal Pharmaceuticals | $476 | Travel and Lodging | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-18 | Madrigal Pharmaceuticals | $244 | Travel and Lodging | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-18 | Madrigal Pharmaceuticals | $196 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-18 | Madrigal Pharmaceuticals | $102 | Travel and Lodging | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-07-02 | Shionogi Inc | $1 | Education | In-kind items and services | Fetroja Drug, Infections and Infectious Diseases | 2025 | |
| 2025-06-27 | ABBVIE INC. | $446 | Travel and Lodging | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-06-27 | ABBVIE INC. | $190 | Travel and Lodging | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-06-27 | ABBVIE INC. | $150 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-06-27 | ABBVIE INC. | $70 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-06-27 | ABBVIE INC. | $60 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-06-27 | ABBVIE INC. | $40 | Travel and Lodging | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-06-27 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-06-27 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-06-27 | ABBVIE INC. | $25 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-06-26 | Madrigal Pharmaceuticals | $2,635 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-06-26 | Madrigal Pharmaceuticals | $1,074 | Travel and Lodging | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-06-26 | Madrigal Pharmaceuticals | $71 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-06-18 | Insmed, Inc. | $20 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-06-17 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-06-02 | Gilead Sciences, Inc. | $2,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Epclusa Drug, HCV | 2025 | |
| 2025-05-21 | ABBVIE INC. | $65 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-05-21 | Insmed, Inc. | $11 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-05-20 | Gilead Sciences, Inc. | $1,756 | Travel and Lodging | In-kind items and services | Epclusa Drug, HCV | 2025 | |
| 2025-05-20 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-05-16 | Gilead Sciences, Inc. | $3,770 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Epclusa Drug, HCV | 2025 | |
| 2025-05-16 | Gilead Sciences, Inc. | $2,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Epclusa Drug, HCV | 2025 | |
| 2025-05-16 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-05-15 | Gilead Sciences, Inc. | $121 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2025 | |
| 2025-05-15 | Gilead Sciences, Inc. | $23 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2025 | |
| 2025-05-14 | Madrigal Pharmaceuticals | $2,170 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-05-14 | Madrigal Pharmaceuticals | $1,563 | Travel and Lodging | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-05-14 | Madrigal Pharmaceuticals | $139 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-05-03 | ABBVIE INC. | $546 | Travel and Lodging | In-kind items and services | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-05-03 | ABBVIE INC. | $326 | Travel and Lodging | In-kind items and services | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-05-03 | ABBVIE INC. | $68 | Food and Beverage | In-kind items and services | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-05-03 | ABBVIE INC. | $54 | Food and Beverage | In-kind items and services | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-05-03 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-05-02 | ABBVIE INC. | $149 | Food and Beverage | In-kind items and services | EMBLAVEO Drug, ANTI-INFECTIVE | 2025 | |
| 2025-04-27 | Insmed, Inc. | $12 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-04-15 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | ZERBAXA Drug, INFECTIOUS DISEASE | 2025 | |
| 2025-04-11 | Shionogi Inc | $1,262 | Consulting Fee | Cash or cash equivalent | S-217622 Drug, Infections and Infectious Diseases | 2025 | |
| 2025-04-08 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-04-08 | Gilead Sciences, Inc. | $2 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-27 | Shionogi Inc | $1,000 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2025 | |
| 2025-03-25 | ABBVIE INC. | $7 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-03-24 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | DALVANCE Drug, ANTI-INFECTIVE | 2025 | |
| 2025-03-18 | Madrigal Pharmaceuticals | $1,705 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-03-18 | Madrigal Pharmaceuticals | $90 | Food and Beverage | In-kind items and services | REZDIFFRA Drug, LIVER DISEASE | 2025 | |
| 2025-03-18 | Insmed, Inc. | $11 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-03-17 | Gilead Sciences, Inc. | $21 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-03-13 | Gilead Sciences, Inc. | $6,190 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Epclusa Drug, HCV | 2025 | |
| 2025-03-11 | Merck Sharp & Dohme LLC | $20 | Food and Beverage | In-kind items and services | ZERBAXA Drug, INFECTIOUS DISEASE | 2025 | |
| 2025-03-01 | Gilead Sciences, Inc. | $284 | Travel and Lodging | In-kind items and services | Epclusa Drug, HCV | 2025 | |
| 2025-03-01 | Gilead Sciences, Inc. | $59 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2025 | |
| 2025-03-01 | Gilead Sciences, Inc. | $57 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2025 | |
| 2025-03-01 | Gilead Sciences, Inc. | $47 | Travel and Lodging | In-kind items and services | Epclusa Drug, HCV | 2025 | |
| 2025-02-28 | Gilead Sciences, Inc. | $142 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2025 | |
| 2025-02-25 | Merck Sharp & Dohme LLC | $23 | Food and Beverage | In-kind items and services | ZERBAXA Drug, INFECTIOUS DISEASE | 2025 | |
| 2025-02-24 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-02-10 | Gilead Sciences, Inc. | $21 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-02-03 | Insmed, Inc. | $12 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-01-28 | Merck Sharp & Dohme LLC | $19 | Food and Beverage | In-kind items and services | ZERBAXA Drug, INFECTIOUS DISEASE | 2025 | |
| 2025-01-27 | ABBVIE INC. | $16 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2025 | |
| 2025-01-24 | Philips North America LLC | $75 | Food and Beverage | Cash or cash equivalent | IGT Devices Undivided Device, Medical Device | 2025 | |
| 2025-01-14 | Insmed, Inc. | $11 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2025 | |
| 2025-01-13 | Gilead Sciences, Inc. | $21 | Food and Beverage | In-kind items and services | 2025 | ||
| 2024-12-12 | Gilead Sciences, Inc. | $12 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-12-09 | Gilead Sciences, Inc. | $43 | Travel and Lodging | In-kind items and services | Epclusa Drug, HCV | 2024 | |
| 2024-12-09 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-11-19 | Gilead Sciences, Inc. | $16 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-11-12 | Gilead Sciences, Inc. | $2,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Epclusa Drug, HCV | 2024 | |
| 2024-11-11 | Gilead Sciences, Inc. | $27 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2024 | |
| 2024-11-06 | Madrigal Pharmaceuticals | $60 | Food and Beverage | In-kind items and services | RESMETIROM Drug, LIVER DISEASE | 2024 | |
| 2024-11-05 | Corcept Therapeutics | $18 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2024 | |
| 2024-10-22 | Shionogi Inc | $3,030 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2024 | |
| 2024-10-17 | ABBVIE INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-10-14 | Shionogi Inc | $124 | Food and Beverage | In-kind items and services | Fetroja Drug, Infections and Infectious Diseases | 2024 | |
| 2024-10-14 | Abbott Laboratories | $17 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2024 | |
| 2024-10-07 | ABBVIE INC. | $5 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-09-23 | ABBVIE INC. | $1,940 | Travel and Lodging | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-09-23 | ABBVIE INC. | $161 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-09-18 | Gilead Sciences, Inc. | $2,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Epclusa Drug, HCV | 2024 | |
| 2024-09-16 | Gilead Sciences, Inc. | $32 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2024 | |
| 2024-09-11 | Gilead Sciences, Inc. | $14 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-09-10 | ABBVIE INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DALVANCE Drug, ANTI-INFECTIVE | 2024 | |
| 2024-08-16 | Lilly USA, LLC | $18 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-08-14 | Gilead Sciences, Inc. | $13 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-08-13 | ABBVIE INC. | $1,528 | Travel and Lodging | In-kind items and services | DALVANCE Drug, ANTI-INFECTIVE | 2024 | |
| 2024-08-13 | ABBVIE INC. | $124 | Food and Beverage | In-kind items and services | DALVANCE Drug, ANTI-INFECTIVE | 2024 | |
| 2024-08-08 | Gilead Sciences, Inc. | $600 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-07-24 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-07-23 | Amgen Inc. | $13 | Food and Beverage | In-kind items and services | TAVNEOS Drug, Inflammation | 2024 | |
| 2024-07-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | $27 | Food and Beverage | In-kind items and services | OFEV Drug, RESPIRATORY | 2024 | |
| 2024-07-11 | Merck Sharp & Dohme LLC | $17 | Food and Beverage | In-kind items and services | DIFICID Drug, INFECTIOUS DISEASE | 2024 | |
| 2024-07-10 | ABBVIE INC. | $27 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-06-20 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-06-13 | Gilead Sciences, Inc. | $14 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-06-12 | ABBVIE INC. | $8 | Food and Beverage | In-kind items and services | DALVANCE Drug, ANTI-INFECTIVE | 2024 | |
| 2024-06-11 | Shionogi Inc | $4,545 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2024 | |
| 2024-05-31 | ABBVIE INC. | $21 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-05-23 | Gilead Sciences, Inc. | $15 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-05-20 | Lilly USA, LLC | $17 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-05-16 | Insmed, Inc. | $20 | Food and Beverage | In-kind items and services | Arikayce Drug, Respiratory | 2024 | |
| 2024-05-09 | Shionogi Inc | $1,673 | Travel and Lodging | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2024 | |
| 2024-05-09 | Shionogi Inc | $97 | Food and Beverage | In-kind items and services | Fetroja Drug, Infections and Infectious Diseases | 2024 | |
| 2024-04-26 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-04-25 | Gilead Sciences, Inc. | $14 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-04-23 | Amgen Inc. | $13 | Food and Beverage | In-kind items and services | TAVNEOS Drug, Inflammation | 2024 | |
| 2024-04-17 | Gilead Sciences, Inc. | $2,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Epclusa Drug, HCV | 2024 | |
| 2024-04-16 | Corcept Therapeutics | $21 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2024 | |
| 2024-04-15 | Gilead Sciences, Inc. | $28 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2024 | |
| 2024-04-10 | Boehringer Ingelheim Pharmaceuticals, Inc. | $14 | Food and Beverage (2 payments) | In-kind items and services | JARDIANCE Drug, DIABETES | 2024 | |
| 2024-04-08 | Amgen Inc. | $31 | Food and Beverage | In-kind items and services | Enbrel Biological, Inflammation | 2024 | |
| 2024-04-03 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2024 | |
| 2024-03-27 | Shionogi Inc | $3,030 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | Fetroja Drug, Infections and Infectious Diseases | 2024 | |
| 2024-03-27 | Shionogi Inc | $21 | Food and Beverage | In-kind items and services | Fetroja Drug, Infections and Infectious Diseases | 2024 | |
| 2024-03-26 | ABBVIE INC. | $2,250 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DALVANCE Drug, ANTI-INFECTIVE | 2024 | |
| 2024-03-19 | Gilead Sciences, Inc. | $2,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Epclusa Drug, HCV | 2024 | |
| 2024-03-18 | Gilead Sciences, Inc. | $25 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2024 | |
| 2024-03-15 | ABBVIE INC. | $19 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-03-13 | Abbott Laboratories | $18 | Food and Beverage | In-kind items and services | FREESTYLE LIBRE 3 Device, Diabetes Care | 2024 | |
| 2024-03-13 | Corcept Therapeutics | $14 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2024 | |
| 2024-03-12 | Gilead Sciences, Inc. | $2,900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Epclusa Drug, HCV | 2024 | |
| 2024-03-12 | Shionogi Inc | $505 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | 2024 | ||
| 2024-03-08 | Gilead Sciences, Inc. | $5 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-03-07 | Gilead Sciences, Inc. | $19 | Food and Beverage | In-kind items and services | Epclusa Drug, HCV | 2024 | |
| 2024-03-06 | Lilly USA, LLC | $19 | Food and Beverage | In-kind items and services | JARDIANCE Drug, Diabetes | 2024 | |
| 2024-03-02 | Gilead Sciences, Inc. | $298 | Travel and Lodging | In-kind items and services | 2024 | ||
| 2024-03-02 | Gilead Sciences, Inc. | $49 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-03-02 | Gilead Sciences, Inc. | $49 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-03-01 | ABBVIE INC. | $31 | Food and Beverage | In-kind items and services | DALVANCE Drug, ANTI-INFECTIVE | 2024 | |
| 2024-02-28 | ABBVIE INC. | $6 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-02-28 | ABBVIE INC. | $0 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-02-27 | Corcept Therapeutics | $18 | Food and Beverage | In-kind items and services | Korlym Drug, Endocrinology | 2024 | |
| 2024-02-27 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-02-22 | Gilead Sciences, Inc. | $15 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-02-22 | Gilead Sciences, Inc. | $11 | Education | In-kind items and services | Veklury Drug, COVID-19 | 2024 | |
| 2024-02-12 | Amgen Inc. | $29 | Food and Beverage | In-kind items and services | Enbrel Biological, Inflammation | 2024 | |
| 2024-02-08 | Gilead Sciences, Inc. | $3,240 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | 2024 | ||
| 2024-02-08 | Amgen Inc. | $15 | Food and Beverage | In-kind items and services | EVENITY Biological, Bone Health | 2024 | |
| 2024-02-06 | ABBVIE INC. | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | DALVANCE Drug, ANTI-INFECTIVE | 2024 | |
| 2024-02-06 | Gilead Sciences, Inc. | $3 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-29 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | TEFLARO Drug, ANTI-INFECTIVE | 2024 | |
| 2024-01-23 | ABBVIE INC. | $1,406 | Travel and Lodging | In-kind items and services | DALVANCE Drug, ANTI-INFECTIVE | 2024 | |
| 2024-01-23 | ABBVIE INC. | $83 | Food and Beverage | In-kind items and services | DALVANCE Drug, ANTI-INFECTIVE | 2024 | |
| 2024-01-19 | ABBVIE INC. | $14 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2024-01-10 | Gilead Sciences, Inc. | $14 | Food and Beverage | In-kind items and services | 2024 | ||
| 2024-01-05 | ABBVIE INC. | $4 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2024 | |
| 2023-12-21 | ABBVIE INC. | $12 | Food and Beverage | In-kind items and services | AVYCAZ Drug, ANTI-INFECTIVE | 2023 | |
| 2023-12-08 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | MAVYRET Drug, VIROLOGY | 2023 | |
| 2023-12-06 | Mallinckrodt Hospital Products Inc. | $35 | Food and Beverage | In-kind items and services | ACTHAR Biological, IMMUNOLOGY | 2023 | |
| 2023-12-05 | Merck Sharp & Dohme LLC | $9 | Food and Beverage | In-kind items and services | DIFICID Drug, INFECTIOUS DISEASE | 2023 | |
| 2023-11-30 | Shionogi Inc | $2,500 | Compensation for serving as faculty or as a speaker for a medical education program | Cash or cash equivalent | 2023 | ||
| 2023-11-30 | Shionogi Inc | $63 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-30 | Shionogi Inc | $47 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-30 | Shionogi Inc | $35 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-11-29 | Shionogi Inc | $466 | Travel and Lodging | Cash or cash equivalent | 2023 |
The latest 200 records of 572.
Research payments naming this person as principal investigator
| Date | Company | Paid to | Amount | Study | Year |
|---|---|---|---|---|---|
| 2022-12-31 | ABBVIE INC. | PIKEVILLE MEDICAL CENTER | $3 | Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves | 2022 |
| 2022-03-31 | ABBVIE INC. | PIKEVILLE MEDICAL CENTER | $24,918 | Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves | 2022 |
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Pikeville, KY, county Pike County, KY, state Kentucky; placed by its city name.
| Measure | Place (city or town) Pikeville, KY | County Pike County, KY | State Kentucky |
|---|---|---|---|
| Population B01003 | 7,490 | 56,727 | 4,534,824 |
| Population, 2020 census P1 | 7,754 | 58,669 | 4,505,836 |
| Median age B01002 | 40.4 | 43.3 | 39.1 |
| Under 18 B01001 | 15.1% | 20.3% | 22.6% |
| 65 and over B01001 | 17.1% | 20.1% | 17.3% |
| Households B11001 | 3,323 | 24,284 | 1,814,469 |
| Foreign born B05002 | 4.6% | 0.9% | 4.7% |
| Median household income B19013 | $39,955 | $44,312 | $63,726 |
| Median family income B19113 | $73,732 | $63,028 | $81,505 |
| Per capita income B19301 | $33,301 | $27,048 | $35,821 |
| Poverty rate B17001 | 27.1% | 24.4% | 16.1% |
| Unemployment rate B23025 | 3.2% | 5.2% | 4.9% |
| Civilian labor force B23025 | 2,766 | 20,300 | 2,152,038 |
| Mean commute (minutes) B08013 | 13.4 | 25.3 | 24.0 |
| Bachelor's degree or higher B15003 | 40.4% | 17.8% | 27.6% |
| Housing units B25001 | 3,623 | 29,044 | 2,023,116 |
| Owner-occupied B25003 | 40.8% | 75.3% | 68.3% |
| Renters B25003 | 59.2% | 24.7% | 31.7% |
| Median home value B25077 | $263,800 | $112,000 | $205,600 |
| Median gross rent B25064 | $862 | $858 | $967 |
| White, not Hispanic B03002 | 89.6% | 93.9% | 81.5% |
| Black B03002 | 3.5% | 0.6% | 7.6% |
| Hispanic or Latino B03002 | 1.9% | 1.3% | 5.0% |
| Asian B03002 | 2.4% | 0.6% | 1.6% |
| American Indian and Alaska Native B03002 | 0.0% | 0.0% | 0.1% |
Economy now FRED unemployment 4.7% in Sep 2026 (4.5% a year earlier); per capita personal income $60,835 in 2025, up 29% in five years (+3.9% after inflation); the state; Source: FRED, Federal Reserve Bank of St. Louis.
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Pikeville, KY.
Comments